LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination

A 71-year-old male patient was diagnosed with LGI1 encephalopathy 4 weeks following a first ChAdOx1 nCov-19 vaccination. Extensive work-up including analysis of CSF and PET examination did not reveal a tangible cause so that a vaccine-associated encephalopathy was considered as differential diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Garibashvili, Tamara, Heckmann, Josef Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206881/
https://www.ncbi.nlm.nih.gov/pubmed/35718786
http://dx.doi.org/10.1186/s42466-022-00187-8
Descripción
Sumario:A 71-year-old male patient was diagnosed with LGI1 encephalopathy 4 weeks following a first ChAdOx1 nCov-19 vaccination. Extensive work-up including analysis of CSF and PET examination did not reveal a tangible cause so that a vaccine-associated encephalopathy was considered as differential diagnosis. Under steroid treatment, the faciobrachial dystonic seizures subsided.

Ejemplares similares